55 related articles for article (PubMed ID: 1188794)
1. Proceedings: Animal experiments of a new synthetic thrombin-inhibitor, dansyl-arginine-methyl-piperidine amide.
Hijikate A; Okamoto S; Ikezawa K; Kikimoto R; Tonomura S; Tamao Y
Thromb Diath Haemorrh; 1975 Sep; 34(1):347-8. PubMed ID: 1188794
[No Abstract] [Full Text] [Related]
2. Proceedings: A series of extremely potent thrombin-inhibitors newly synthetized.
Okamoto S; Hijikata A; Kikumoto R; Tonomura S; Tamao Y
Thromb Diath Haemorrh; 1975 Sep; 34(1):364-5. PubMed ID: 1188831
[No Abstract] [Full Text] [Related]
3. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
Hijikata A; Okamoto S; Kikumoto R; Tamao Y
Thromb Haemost; 1979 Oct; 42(3):1039-45. PubMed ID: 159513
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of a new structural variant of 4-amidinophenylalanine amide-type synthetic thrombin inhibitor.
Hauptmann J; Kaiser B; Paintz M; Markwardt F
Pharmazie; 1989 Apr; 44(4):282-4. PubMed ID: 2772004
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on thrombin inhibitors in experimental microthrombosis.
Markwardt F; Nowak G; Hoffmann J
Thromb Haemost; 1983 Jun; 49(3):235-7. PubMed ID: 6603675
[TBL] [Abstract][Full Text] [Related]
6. Comparison of plasma levels and excretory routes between No. 189 and No. 407, potent thrombin inhibitors.
Oda K; Ohtsu K; Tamao Y; Kikumoto R; Hijikata A; Kinjo K; Okamoto S
Kobe J Med Sci; 1980 Mar; 26(1):11-31. PubMed ID: 7392547
[No Abstract] [Full Text] [Related]
7. Inhibited thrombins. Interactions with fibrinogen and fibrin.
Kaminski M; McDonagh J
Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
[TBL] [Abstract][Full Text] [Related]
8. Synthetic selective inhibitors of thrombin.
Okamoto S; Hijikata-Okunomiya A
Methods Enzymol; 1993; 222():328-40. PubMed ID: 8412802
[No Abstract] [Full Text] [Related]
9. Thrombin inhibitors. 2. Amide derivatives of N alpha-substituted L-arginine.
Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Okamoto S; Funahara Y; Hijikata A
J Med Chem; 1980 Aug; 23(8):830-6. PubMed ID: 7401110
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.
Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
Prog Clin Biol Res; 1982; 89():479-502. PubMed ID: 6287488
[No Abstract] [Full Text] [Related]
11. Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
Nesheim ME; Prendergast FG; Mann KG
Biochemistry; 1979 Mar; 18(6):996-1003. PubMed ID: 427102
[No Abstract] [Full Text] [Related]
12. A novel series of synthetic thrombin-inhibitors having extremely potent and highly selective action.
Okamoto S; Hijikata A; Kinjo K; Kikumoto R; Okubo K
Kobe J Med Sci; 1975 Jun; 21(2):43-51. PubMed ID: 1160331
[No Abstract] [Full Text] [Related]
13. Thrombin inhibitors. 1. Ester derivatives of N alpha-(arylsulfonyl)-L-arginine.
Okamoto S; Kinjo K; Hijikata A; Kikumoto R; Tamao Y; Ohkubo K; Tonomura S
J Med Chem; 1980 Aug; 23(8):827-30. PubMed ID: 7401109
[TBL] [Abstract][Full Text] [Related]
14. Isolation and autolysis of human meizothrombin in the presence of dansylarginine-N-(3-ethyl-1,5-pentanediyl)amide.
Pei G; Lentz BR
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):309-16. PubMed ID: 1893062
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine.
Salvagnini C; Gharbi S; Boxus T; Marchand-Brynaert J
Eur J Med Chem; 2007 Jan; 42(1):37-53. PubMed ID: 17010480
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of a new highly effective synthetic thrombin inhibitor.
Kaiser B; Hauptmann J; Weiss A; Markwardt F
Biomed Biochim Acta; 1985; 44(7-8):1201-10. PubMed ID: 4084272
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo comparison of arginine- and benzamidine-derived highly potent synthetic thrombin inhibitors.
Hauptmann J; Kaiser B
Pharmazie; 1991 Jan; 46(1):57-8. PubMed ID: 1857734
[No Abstract] [Full Text] [Related]
18. A novel series of synthetic thrombin-inhibitors. II. Relationships between structure of modified OM-inhibitors and thrombin inhibitory effect.
Tonomura S; Kikumoto R; Tamao Y; Ohkubo K; Okamoto S; Kinjo K; Hijikata A
Kobe J Med Sci; 1980 Mar; 26(1):1-9. PubMed ID: 7190199
[No Abstract] [Full Text] [Related]
19. [Antithrombin activity of methyl esters of arginine-containing peptides].
Kostiuchenko NV; Romanova VP; Serebrianyĭ SB; Kibirev VK
Ukr Biokhim Zh (1978); 1987; 59(3):8-12. PubMed ID: 3603738
[TBL] [Abstract][Full Text] [Related]
20. Chemical modification of alpha-thrombin and in vitro characterization of its anticoagulant activity.
Nakagomi K; Ajisaka K
Biochem Int; 1990 Oct; 22(1):75-84. PubMed ID: 2177988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
